Research shows that nuclear receptor subfamily 2 group F member 6 (NR2F6) promotes MASLD by activating CD36 gene expression, inducing TG retention, and providing a new molecular basis for hepatic steatosis [109]. This evidence concerns the gene NR2F6 and Hepatic steatosis.